These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 17316760)
1. High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not. Xu H; Bourne PA; Spaulding BO; Wang HL Hum Pathol; 2007 Apr; 38(4):555-63. PubMed ID: 17316760 [TBL] [Abstract][Full Text] [Related]
2. Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas. Pryor JG; Simon RA; Bourne PA; Spaulding BO; Scott GA; Xu H Hum Pathol; 2009 Feb; 40(2):238-43. PubMed ID: 18835627 [TBL] [Abstract][Full Text] [Related]
3. Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not. Simon R; Bourne PA; Yang Q; Spaulding BO; di Sant'Agnese PA; Wang HL; Xu H Hum Pathol; 2007 Aug; 38(8):1178-83. PubMed ID: 17521698 [TBL] [Abstract][Full Text] [Related]
4. High-grade neuroendocrine carcinomas of the lung highly express enhancer of zeste homolog 2, but carcinoids do not. Findeis-Hosey JJ; Huang J; Li F; Yang Q; McMahon LA; Xu H Hum Pathol; 2011 Jun; 42(6):867-72. PubMed ID: 21292308 [TBL] [Abstract][Full Text] [Related]
5. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study. Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030 [TBL] [Abstract][Full Text] [Related]
6. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
7. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. LaPoint RJ; Bourne PA; Wang HL; Xu H Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382 [TBL] [Abstract][Full Text] [Related]
8. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Hanley KZ; Facik MS; Bourne PA; Yang Q; Spaulding BO; Bonfiglio TA; Xu H Cancer; 2008 Feb; 114(1):49-56. PubMed ID: 18098206 [TBL] [Abstract][Full Text] [Related]
9. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721 [TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
11. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246 [TBL] [Abstract][Full Text] [Related]
12. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
13. Frequent overexpression of the c-kit protein in large cell neuroendocrine carcinoma of the lung. Araki K; Ishii G; Yokose T; Nagai K; Funai K; Kodama K; Nishiwaki Y; Ochiai A Lung Cancer; 2003 May; 40(2):173-80. PubMed ID: 12711118 [TBL] [Abstract][Full Text] [Related]
14. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors. Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584 [TBL] [Abstract][Full Text] [Related]
15. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas. Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410 [TBL] [Abstract][Full Text] [Related]
17. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Yantiss RK; Woda BA; Fanger GR; Kalos M; Whalen GF; Tada H; Andersen DK; Rock KL; Dresser K Am J Surg Pathol; 2005 Feb; 29(2):188-95. PubMed ID: 15644775 [TBL] [Abstract][Full Text] [Related]
18. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors. Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920 [TBL] [Abstract][Full Text] [Related]
19. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Du EZ; Goldstraw P; Zacharias J; Tiffet O; Craig PJ; Nicholson AG; Weidner N; Yi ES Hum Pathol; 2004 Jul; 35(7):825-31. PubMed ID: 15257545 [TBL] [Abstract][Full Text] [Related]